We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Psychedelics

Psychedelics

Drug-finding Tool Identifies Psychedelic-like Drug That Is Hallucination-free

A new technology developed by researchers at the University of California Davis promises to fast-track the development of compounds that could exploit psychedelics’ therapeutic action without hallucinogenic side effects.

Read More

Psilocybin Compared to Antidepressant in Breakthrough Trial

A new trial has directly compared the antidepressant effects of psilocybin with a more classical antidepressant, and found that the two are matched in their mood-altering potential.

Read More

Could a Chemical Flip Produce a More Effective Ketamine-based Antidepressant?

Drug developers say that R-ketamine could potentially deliver a more targeted action with fewer side effects than its more popular chemical twin.

Read More

Could the “Spirit Molecule” DMT Assist in Stroke Recovery?

N,N-dimethyltryptamine (DMT) is a psychedelic compound under investigation for a range of therapeutic uses. One avenue of research is being pursued by Algernon Pharmaceuticals, who are investigating whether sub-hallucinogenic DMT doses could help to protect and repair the brain in the hours after a stroke.

Read More

The Current State of Psychedelic Research

Scientific research groups have only begun investigating the properties of psychedelic compounds relatively recently. But what have they uncovered so far?

Read More

A Microdosing High is Mostly a Placebo Effect, Psychedelic Study Suggests

People may not have to microdose psychedelics to feel their wellbeing benefits – they just have to believe they’ve microdosed them, according to researchers from Imperial College London.

Read More

Behind the World-First Export of Jamaican Psilocybin Mushrooms

The biotech and life sciences company Mydecine Innovations Group recently announced it had completed its first commercial export of legal psychedelic psilocybin mushrooms from Jamaica to Canada. Technology Networks caught up with the company's chief scientific officer, Rob Roscow, to find out more.

Read More

MDMA-assisted Therapy a “Promising New Treatment” for PTSD, Finds Review

The researchers found MDMA-assisted psychotherapy to have a particularly “impressive effect size” in reducing PTSD symptoms. But they say more studies will be needed before the drug can be recommended for clinical practice.

Read More

Canadian Cannabis Lab Gets Approval to Study Psilocybin

The team at Complex Biotech Discovery Ventures, based in Vancouver, intend to expand the current knowledge base for the psilocybin mushrooms and create a compound library describing the major and minor chemical constituents that make up these mushrooms.

Read More

 
Advertisement